
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 4.510 | 4.510 | 0.000 |
Shares | 95.930 | 95.930 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 20.006 | 19.721 |
Price to Book | 5.550 | 3.900 |
Price to Sales | 2.804 | 2.233 |
Price to Cash Flow | 17.668 | 14.997 |
Dividend Yield | 1.283 | 1.495 |
5 Years Earnings Growth | 7.533 | 9.862 |
Number of long holdings: 32
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vertex | US92532F1003 | 7.71 | 366.54 | -2.42% | |
Gilead | US3755581036 | 7.37 | 119.41 | +8.28% | |
Eli Lilly | US5324571083 | 7.25 | 625.65 | -2.37% | |
Amgen | US0311621009 | 6.32 | 288.23 | +1.24% | |
Lonza Group | CH0013841017 | 5.84 | 544.60 | -0.95% | |
Alnylam | US02043Q1076 | 5.39 | 438.93 | +0.88% | |
Boston Scientific | US1011371077 | 5.36 | 103.14 | +0.17% | |
Neurocrine | US64125C1099 | 4.87 | 125.01 | -0.47% | |
AstraZeneca | GB0009895292 | 4.66 | 10,922.0 | -0.26% | |
AbbVie | US00287Y1091 | 4.44 | 198.05 | -0.41% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Nomura Taiwan Superior Equity Fund | 26.87B | 7.54 | 27.40 | 18.85 | ||
Nomura Global Equity Fund TWD | 12.71B | 1.64 | 15.91 | 10.53 | ||
Nomura Taiwan Small Cap Fund | 10.04B | 4.67 | 27.33 | 19.09 | ||
Nomura Taiwan Growth Fund | 2.89B | 6.72 | 29.95 | 18.59 | ||
Nomura Taiwan Growth Selection Fund | 2.29B | 7.22 | 31.45 | 18.09 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review